Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23.6Revenue (TTM) $M0.3Net Margin (%)-4,023.2Altman Z-Score-36.3
Enterprise Value $M22.4EPS (TTM) $-0.2Operating Margin %-8,966.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score4.9Pre-tax Margin (%)-4,023.2Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsN
Price/Sales65.05-y EBITDA Growth Rate %-23.2Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M189ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CVM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CVM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CVM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KERSTEN GEERT RCEO 2014-10-13Buy14,999$0.77-83.12view
KERSTEN GEERT RCEO 2013-12-30Buy300,000$0.6-78.33view
KERSTEN GEERT RChief Executive 2013-10-09Buy8,400$0.79-83.54view
YOUNG PETER RDirector 2013-06-19Buy2,500$2.4-94.58view
KERSTEN GEERT RChief Executive 2013-06-14Buy14,512$2.4-94.58view
KERSTEN GEERT RCEO 2013-05-20Buy4,000$2.5-94.8view
KERSTEN GEERT RCEO 2013-05-02Buy11,870$2.7-95.19view
YOUNG PETER RDirector 2013-03-27Buy2,500$2.3-94.35view
PRICHEP PATRICIA BSenior Vice President 2013-03-27Buy2,500$2.2-94.09view
KERSTEN GEERT RCEO 2013-03-26Buy34,813$2.1-93.81view

Press Releases about CVM :

Quarterly/Annual Reports about CVM:

News about CVM:

Articles On GuruFocus.com
CELSCISci Corp Reports Operating Results (10-Q) Feb 09 2011 
CELSCISci Corp Reports Operating Results (10-Q) Aug 16 2010 
CELSCISci Corp Reports Operating Results (10-Q) May 17 2010 
CELSCISci Corp Reports Operating Results (10-Q) Feb 12 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Jan 29 2010 
CELSCISci Corp Reports Operating Results (10-K) Jan 13 2010 
CELSCISci Corp Reports Operating Results (10-Q) Aug 14 2009 
CELSCISci Corp Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
CEL SCI CORP Files SEC form 8-K, Other Events Dec 22 2016
NEW STORY CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 21 2016
CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 20 2016
CEL SCI CORP Financials Dec 20 2016
Cel-Sci reports 4Q loss Dec 14 2016
Cel-Sci reports 4Q loss Dec 14 2016
CEL-SCI Reports Fiscal 2016 Financial Results and Clinical & Corporate Developments Dec 14 2016
CEL SCI CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Dec 14 2016
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan Dec 09 2016
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 02 2016
CEL-SCI Announces Pricing of $4.25 Million Public Offering of Common Stock and Warrants Dec 02 2016
CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants Dec 01 2016
NEW STORY CEL-SCI Submits Response to FDA in Connection with Partial Clinical Hold on Phase 3... Nov 21 2016
CEL-SCI Submits Response to FDA in Connection with Partial Clinical Hold on Phase 3 Clinical Trial Nov 21 2016
NEW STORY CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine Is Successful In Treating... Nov 14 2016
CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treating Rheumatoid... Nov 14 2016
NEW STORY CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial Oct 21 2016
CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial Oct 21 2016
ETF’s with exposure to CEL-SCI Corp. : October 18, 2016 Oct 18 2016
CVR Medical Retains Brisco Capital Investor Relations Sep 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)